Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Treace Medical Concepts Inc (TMCI)

Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 441,063
  • Shares Outstanding, K 62,297
  • Annual Sales, $ 187,120 K
  • Annual Income, $ -49,530 K
  • EBIT $ -62 M
  • EBITDA $ -58 M
  • 60-Month Beta 0.66
  • Price/Sales 2.32
  • Price/Cash Flow N/A
  • Price/Book 4.13

Options Overview Details

View History
  • Implied Volatility 103.05% ( +3.50%)
  • Historical Volatility 45.16%
  • IV Percentile 73%
  • IV Rank 49.68%
  • IV High 200.14% on 07/03/24
  • IV Low 7.20% on 09/17/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 8
  • Volume Avg (30-Day) 57
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 7,340
  • Open Int (30-Day) 14,442

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.03
  • Number of Estimates 4
  • High Estimate -0.02
  • Low Estimate -0.05
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +70.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.75 +4.89%
on 12/19/24
8.83 -19.82%
on 12/02/24
-1.20 (-14.49%)
since 11/26/24
3-Month
4.54 +55.95%
on 10/31/24
8.83 -19.82%
on 12/02/24
+1.28 (+22.07%)
since 09/26/24
52-Week
3.92 +80.61%
on 05/08/24
15.98 -55.69%
on 02/12/24
-5.61 (-44.21%)
since 12/26/23

Most Recent Stories

More News
Treace Medical Concepts Announces Successful First Cases of SpeedPlateâ„¢ MicroQuadâ„¢ Implants for Minimally Invasive Bunion Surgery

Treace Medical Concepts reports successful initial cases of its SpeedPlateâ„¢ MicroQuadâ„¢ implants for minimally invasive bunion surgeries.Quiver AI SummaryTreace Medical Concepts, Inc. has announced...

TMCI : 7.08 (+1.58%)
Treace Announces First Surgical Cases Utilizing the SpeedPlateâ„¢ MicroQuadâ„¢ Implant

TMCI : 7.08 (+1.58%)
Treace Medical Concepts Announces Successful First Cases of IntelliGuide™ PSI Technology with Adductoplasty® System for Bunion Treatment

Treace Medical Concepts announced successful use of IntelliGuide™ PSI technology with Adductoplasty® for personalized midfoot deformity corrections.Quiver AI SummaryTreace Medical Concepts, Inc. has...

TMCI : 7.08 (+1.58%)
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities

TMCI : 7.08 (+1.58%)
Treace Medical Concepts Appoints Guy Guglielmino as Chief Commercial Officer to Drive Innovation and Growth

Treace Medical Concepts appoints Guy Guglielmino as Chief Commercial Officer to enhance innovation and growth in bunion treatment.Quiver AI SummaryTreace Medical Concepts, a medical technology firm focused...

TMCI : 7.08 (+1.58%)
Treace Appoints Guy Guglielmino as Chief Commercial Officer

TMCI : 7.08 (+1.58%)
Treace Medical Concepts to Participate in Fireside Chat at Stifel 2024 Healthcare Conference

Treace Medical Concepts executives will speak at the Stifel Healthcare Conference on November 19, 2024, via webcast.Quiver AI SummaryTreace Medical Concepts, Inc. announced that CEO John T. Treace and...

TMCI : 7.08 (+1.58%)
Treace Announces Participation at Stifel 2024 Healthcare Conference

TMCI : 7.08 (+1.58%)
Treace Medical Concepts: Q3 Earnings Snapshot

Treace Medical Concepts: Q3 Earnings Snapshot

TMCI : 7.08 (+1.58%)
Treace Medical Concepts Reports Third Quarter 2024 Financial Results

TMCI : 7.08 (+1.58%)

Business Summary

Treace Medical Concepts Inc. is a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus. Treace Medical Concepts Inc. is based in PONTE VEDRA, Fla.

See More

Key Turning Points

3rd Resistance Point 7.56
2nd Resistance Point 7.34
1st Resistance Point 7.21
Last Price 7.08
1st Support Level 6.86
2nd Support Level 6.64
3rd Support Level 6.51

See More

52-Week High 15.98
Fibonacci 61.8% 11.37
Fibonacci 50% 9.95
Fibonacci 38.2% 8.53
Last Price 7.08
52-Week Low 3.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar